Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
Breadcrumb Trail Links PMN Press Releases Business Wire News Releases Author of the article: Published Apr 26, 2024 • 12 minute read Article content − If Approved in the European Union, Fruquintinib Will Be the First Novel Targeted Therapy for Metastatic …